We are pleased to announce that we now accept all major credit cards, as well as HSA and FSA for payment!
Call Us Today!
Click here now
Click here now
Call Us Today!
Click here now
Click here now
Vaginal dryness occurs when vaginal tissues do not have enough moisture or lubrication. It can cause burning, irritation, itching, discomfort during daily activities, and pain with sexual activity. Although it is common during perimenopause and after menopause, it may also be related to medications, breastfeeding, cancer treatment, infection, or skin conditions.
Effective vaginal dryness treatment depends on the cause and the symptoms affecting the patient. Options may include moisturizers, lubricants, low-dose vaginal estrogen, other prescription medications, or broader menopause hormone therapy when additional symptoms are present. Optimal Female & Men’s Wellness helps women understand what may be contributing to discomfort and explore an individualized care plan.
When estrogen levels decline, the vaginal lining may become thinner, less elastic, and less naturally lubricated. These changes may cause dryness, burning, itching, tenderness, or a feeling of tightness.
Dryness may also occur with urinary urgency, frequent urination, burning, or recurring urinary tract infections. When vaginal, vulvar, sexual, and urinary changes are related to lower estrogen levels, they may be called genitourinary syndrome of menopause, or GSM.
Unlike hot flashes, vaginal and urinary tissue changes often continue or worsen without treatment.
Perimenopause and menopause are common causes because declining estrogen affects tissue thickness, elasticity, blood flow, and natural lubrication.
Other possible causes include breastfeeding, certain allergy medications, some antidepressants, chemotherapy, pelvic radiation, and hormonal cancer treatments. Scented soaps, douches, perfumed wipes, and other irritants may also worsen symptoms.
Yeast infections, bacterial infections, sexually transmitted infections, vulvar skin disorders, and pelvic floor concerns can feel similar. Persistent dryness should therefore not be assumed to be hormonal without an appropriate evaluation.
An evaluation may include questions about when symptoms began, menstrual changes, sexual discomfort, urinary symptoms, medications, cancer history, and products used around the vulva or vagina.
A pelvic examination may be recommended to look for tissue changes, irritation, infection, or another source of pain. Testing may be needed when discharge, odor, sores, bleeding, or possible infection symptoms are present.
Hormone blood tests are not usually required for typical menopause-related vaginal dryness.
Bleeding after menopause, unexplained bleeding, new pelvic pain, or persistent sores should be assessed promptly rather than treated only with over-the-counter products.
Vaginal moisturizers and lubricants are common first steps, but they serve different purposes. A moisturizer is used regularly to support moisture between sexual activities. A lubricant is applied before sexual activity to reduce friction.
Products containing fragrances, warming ingredients, or other irritants may worsen sensitivity. Oil-based products can damage latex condoms, so compatibility matters when barrier protection is used.
Nonhormonal products may provide relief, but they do not directly restore estrogen-related changes in tissue thickness and elasticity. Women with persistent symptoms may need prescription treatment.
Low-dose vaginal estrogen delivers medication directly to vaginal tissues and may be considered when dryness, irritation, or pain with sex is the main concern. It is available as creams, tablets, inserts, and rings.
Local therapy differs from systemic menopause hormone therapy, which circulates throughout the body and is used for symptoms such as hot flashes.
Patients with a history of breast cancer, uterine cancer, unexplained bleeding, or other complex concerns should discuss treatment with the clinicians involved in their care. Shared decision-making may include an oncologist or gynecologist when appropriate.
Vaginal dehydroepiandrosterone, also called DHEA or prasterone, may help certain menopause-related symptoms, including dryness or pain during sexual activity.
Ospemifene is an oral selective estrogen receptor modulator used for moderate-to-severe vaginal dryness or painful intercourse related to menopause. It has its own risks, precautions, and interactions.
Compounded hormones and device-based treatments should not automatically be considered safer or more effective. Evidence and regulatory oversight vary, and some laser or radiofrequency procedures are not specifically approved to treat GSM.
Some women may benefit from pelvic floor therapy, treatment for a skin condition, evaluation of recurring urinary symptoms, or counseling related to sexual pain.
At Optimal Female & Men’s Wellness, care may include medication management, menopause hormone therapy, nutritional support, or referral when specialized evaluation is needed. Treatment should reflect the complete symptom pattern rather than focus only on dryness.
Vaginal dryness is common, but it does not have to be accepted as an unavoidable part of aging. The right evaluation can distinguish menopause-related tissue changes from infection, medication effects, irritation, or another condition.
Schedule an appointment with Optimal Female & Men’s Wellness to discuss your symptoms and explore vaginal dryness treatment options based on your health history, comfort, and preferences.
Declining estrogen during perimenopause and menopause is a common cause. Medications, breastfeeding, cancer treatment, irritation, and infection can also contribute.
The best treatment depends on the cause and severity. Options may include moisturizers, lubricants, low-dose vaginal estrogen, prasterone, ospemifene, or systemic hormone therapy.
A vaginal moisturizer is used regularly for ongoing dryness. A lubricant is used around sexual activity to reduce friction.
Yes. Estrogen-related tissue changes can cause dryness, burning, itching, and irritation. Infection and skin conditions should also be considered.
Low-dose vaginal estrogen can improve menopause-related dryness, tissue thinning, irritation, and pain with sex in appropriately evaluated patients.
No. Vaginal estrogen mainly targets local tissues, while systemic therapy circulates throughout the body.
Yes. Reduced lubrication and thinner, less elastic tissues can make penetration painful and may cause light bleeding.
Yes. GSM may include urinary urgency, burning, frequent urination, and recurring urinary tract infections.
Seek care when symptoms persist, affect daily life or intimacy, or occur with bleeding, sores, unusual discharge, odor, pelvic pain, or urinary concerns.
Temporary dryness may improve when a short-term trigger changes. Menopause-related tissue changes often persist or worsen without treatment.